Mini-Oral Session

[MO18] Mini-Oral Session 18　Breast Cancer 1（Systemic treatment, Survivership）
【E】

Thu. Feb 17, 2022 1:10 PM - 2:00 PM Room 13 (Gold Room, B2F, The Prince Kyoto Takaragaike)

Chair：Kazuhiro Araki（Department of Medical Oncology, Gunma Prefctral Cancer Center），Yasuhiro Yanagita（Department of Breast Oncology, Gunma Prefectural Cancer Center）

+Add all to schedule

[MO18-1] Impact of Cachexia on Survival Before First-line Chemotherapy for Metastatic Breast Cancer

^○Kazuki Nozawa, Ayaka Isogai, Daiki Takatsuka, Yuka Endo, Yuri Ozaki, Nanae Horisawa, Ayumi Kataoka, Haruru Kotani, Akiyo Yoshimura, Masaya Hattori, Masataka Sawaki, Hiroji Iwata (Department of Breast Oncology, Aichi Cancer Center Hospital)

[MO18-2] A phase II trial of neoadjuvant apatinib combined with nab-paclitaxel and carboplatin in triple-negative breast cancer

^○Tianyu Zeng¹, Jue Wang², Wei Li¹, Chunxiao Sun¹, Fan Yang¹, Yan Liang¹, Ziyi Fu¹, Xiaoming Zha², Yongmei Yin¹ (1.Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, 2.Department of Breast Disease, the First Affiliated Hospital of Nanjing Medical University)

[MO18-3] A novel information sharing system via YouTube to provide breast cancer information and to raise public breast awareness

^○Asumi Iesato^1,2, Mitsuo Terada^2,3, Atsushi Fushimi^2,4, Rie Tahara², Kanako Nishiyama^2,5, Madoka Iwase^2,6, Nami Yamashita^2,7 (1.Department of Pathology, Beth Israel Deaconess Medical Center, 2.BC Tube Association, 3.Department of Breast Surgery, Nagoya City University Graduate School of Medical Sciences, 4.Department of Breast Endocrine Surgery, The Jikei University School of Medicine, 5.Breast Center, Ehime University Hospital, 6.Department of Breast and Endocrine Surgery, Nagoya University Hospital, 7.Medical Oncology, Dana-Farber Cancer Institute)

[MO18-4] The efficacy of palbociclib and subsequent therapy

^○Naoko Iwamoto, Mio Adachi, Yuichi Kumaki, Chiaki Saita, Rika Yonekura, Toshiyuki Ishiba, Noriko Nakatsugawa, Yayoi Honda, Tomoyuki Aruga (Department of Breast Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital)

[MO18-5] SURVIVAL 11: THE NOMOGRAM AND ANDROID APPLICATION TO ESTIMATE THE SURVIVAL RATE OF BREAST CANCER SUBJECTS IN INDONESIA

^○Citra Aryanti, I Wayan Sudarsa, Putu Anda Tusta Adiputra, I Gede Budhi Setiawan (Division of Surgical Oncology, Department of Surgery, Udayana University, Denpasar, Bali, Indonesia)

[MO18-6] Dynamic change in absolute lymphocyte counts during eribulin therapy predicts overall survival in advanced breast cancer

^○Shogo Nakamoto, Ikeda Masahiko, Kubo Shinichiro, Yamamoto Mari, Yamashita Tetsumasa, Kuwahara Chihiro (Department of Breast and Thyroid Gland Surgery, Fukuyama City Hospital)